全球醫療保健生物融合市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計醫療保健生物融合市場將從 2025 年的 455.6 億美元成長到 2034 年的 970.1 億美元，2026 年至 2034 年的複合年成長率為 8.76%。

全球醫療生物融合市場代表著生物學、工程學、資料科學和尖端技術的融合。這種跨學科方法正在透過推動生物工程組織、智慧藥物傳輸系統和先進診斷技術等創新，變革醫療保健產業。對個人化和高效醫療解決方案日益成長的需求，正在推動全球生物融合研發領域的投資。

生物技術、人工智慧和奈米技術的快速發展是推動該領域發展的主要動力。製藥公司和醫療設備製造商正與科技公司合作，共同打造下一代醫療解決方案。精準舉措和再生醫學研究領域資金的增加也促進了市場成長。學術機構和Start-Ups在加速該領域的創新方面發揮著至關重要的作用。

未來，生物融合有望徹底改變醫療保健領域的治療方法和疾病管理。數位科技與生物系統的整合將改善病患監測和治療效果。監管支持和跨行業夥伴關係對於加速創新至關重要。隨著醫療保健系統向更加一體化和技術主導的模式轉型，生物融合市場預計將在未來幾年顯著成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球醫療保健生物融合市場：依應用領域分類

• 市場分析、洞察與預測
• 藥物發現
• 用於藥物遞送的奈米機器人
• 再生醫學
• 診斷和生物感測器
• 生物電子學
• 工程化生命材料
• 光遺傳學
• 精準醫療

第5章 全球醫療保健生物融合市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術產業
• 合約研究組織（CRO）
• 其他

第6章 全球醫療保健生物融合市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Ginkgo Bioworks
  • Thermo Fisher Scientific Inc
  • GE Healthcare
  • Siemens AG
  • BiomX
  • Century Therapeutics
  • Singota Solutions
  • Galvani Bioelectronics
  • Bico Group
  • SetPoint Medical

The Healthcare Bioconvergence Market size is expected to reach USD 97.01 Billion in 2034 from USD 45.56 Billion (2025) growing at a CAGR of 8.76% during 2026-2034.

The Global Healthcare Bioconvergence Market represents the integration of biology with engineering, data science, and advanced technologies. This interdisciplinary approach is transforming healthcare by enabling innovations such as bioengineered tissues, smart drug delivery systems, and advanced diagnostics. Growing demand for personalized and efficient healthcare solutions is driving investment in bioconvergence research and development worldwide.

Major drivers include rapid advancements in biotechnology, artificial intelligence, and nanotechnology. Pharmaceutical and medical device companies are collaborating with tech firms to create next-generation healthcare solutions. Increased funding for precision medicine initiatives and regenerative medicine research is also fueling market growth. Academic institutions and startups play a vital role in accelerating innovation in this field.

Looking forward, healthcare bioconvergence is expected to revolutionize treatment approaches and disease management. The integration of digital technologies with biological systems will enhance patient monitoring and therapeutic outcomes. Regulatory support and cross-industry partnerships will be essential for scaling innovations. As healthcare systems shift toward more integrated and technology-driven models, the bioconvergence market is poised for significant expansion in the years ahead.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Drug Discovery
• Nanorobotics for Drug Delivery
• Regenerative Medicine
• Diagnostic and Biological Sensor
• Bioelectronics
• Engineered Living Materials
• Optogenetics
• Precision Medicine

By End User

• Pharmaceutical & Biotechnology Industry
• Contract Research Organization (CRO)
• Others

COMPANIES PROFILED

• Ginkgo Bioworks, Thermo Fisher Scientific Inc, GE Healthcare, Siemens AG, BiomX, Century Therapeutics, Singota Solutions, Galvani Bioelectronics, Bico Group, SetPoint Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nanorobotics for Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Diagnostic and Biological Sensor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bioelectronics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Engineered Living Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Optogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Precision Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharmaceutical & Biotechnology Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Contract Research Organization (CRO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE BIOCONVERGENCE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Ginkgo Bioworks
  • 8.2.2 Thermo Fisher Scientific Inc
  • 8.2.3 GE Healthcare
  • 8.2.4 Siemens AG
  • 8.2.5 BiomX
  • 8.2.6 Century Therapeutics
  • 8.2.7 Singota Solutions
  • 8.2.8 Galvani Bioelectronics
  • 8.2.9 Bico Group
  • 8.2.10 SetPoint Medical